Will release salary to ex-Ranbaxy MRs using company app: Sun

Image
Press Trust of India New Delhi
Last Updated : Oct 12 2016 | 9:02 PM IST
Backed by a Bombay High Court order, drug major Sun Pharmaceutical Industries today said it will release salaries of the erstwhile Ranbaxy medical representatives only if they used a company provided software application to report daily activity reports.
A section of ex-Ranbaxy medical representatives (MRs) had challenged in the industrial court in Mumbai Sun Pharma's move to do away with a software application used by erstwhile Ranbaxy MRs for reporting daily activity reports (DAR) and asked them to switch over to a system provided by it.
The industrial court had granted an interim oder in favour of the MRs. It was challenged by the company in the Bombay High Court.
The court "has granted the company's request for using the Target Application as the platform for DAR and passed an order in which it has directed the said MRs to start reporting on the Target Application retrospectively", Sun Pharma said in a BSE filing.
"We have stated very clearly in the court that the company will release the salaries provided these medical representatives (MRs) submit their daily activity reports (DAR) using Target Application," it added.
As on today the migration of all MRs of the erstwhile Ranbaxy to Target Application has been completed and around 94 per cent of them are reporting on it. The balance 6 per cent are refusing to submit their DAR on Target Application, Sun Pharma said.
As part of the integration of erstwhile Ranbaxy in Sun Pharma it was decided to use Target Application as a single platform for DAR for the India field force, it added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 12 2016 | 9:02 PM IST

Next Story